EGFR inhibitors embrace KRAS.
Sheridan
Cormac
C
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000235:genetics; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D011905:Genes, ras; D006801:Humans; D009154:Mutation
D000970:Antineoplastic Agents; D066246:ErbB Receptors